COVID-19 vaccination hesitancy among Americans with disabilities aged 18-65 : An exploratory analysis
Copyright © 2021 Elsevier Inc. All rights reserved..
BACKGROUND: It is important for people with disabilities to be vaccinated against COVID-19 because, as a group, they are at increased risk of severe outcomes. While there are multiple vaccines available to prevent COVID-19, a considerable proportion of Americans report some hesitancy to becoming vaccinated, including people with disabilities.
OBJECTIVE: We conducted a study to explore what factors may contribute to COVID-19 vaccination hesitancy among Americans with disabilities.
METHODS: We used Amazon's Mechanical Turk to survey 439 people with disabilities (ages 18+) about their concerns of the COVID-19 disease, vaccines, and hesitancy toward vaccination to learn more about factors that influence vaccination hesitancy. Concerns about vaccines were analyzed as a composite variable representing different dimensions such as: side effects, too new, developed too quickly, influenced by politics, and effectiveness.
RESULTS: Results from a logistic regression indicate that concern about vaccines was the most significant predictor of hesitancy, even after considering demographic, economic, and geographic factors. Concerns about getting COVID-19, getting tested for COVID-19, trust in experts, education, and being a Democrat were negatively associated with hesitancy.
CONCLUSIONS: These findings indicate that some groups of individuals may be more vaccination hesitant because they are more concerned about vaccine safety than COVID-19 infection. Public health messaging that focuses on the risks of vaccines relative to the risks of COVID-19 might be one strategy to reduce hesitancy and increase vaccination uptake. Messaging should also be tailored to specific disabilities (i.e. physical, mental, sensory), written in plain language, and disseminated in accessible formats.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Disability and health journal - 15(2022), 1 vom: 29. Jan., Seite 101223 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Myers, Andrew [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 20.12.2021 Date Revised 03.04.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.dhjo.2021.101223 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM332038556 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM332038556 | ||
003 | DE-627 | ||
005 | 20231225214755.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.dhjo.2021.101223 |2 doi | |
028 | 5 | 2 | |a pubmed24n1106.xml |
035 | |a (DE-627)NLM332038556 | ||
035 | |a (NLM)34663563 | ||
035 | |a (PII)S1936-6574(21)00196-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Myers, Andrew |e verfasserin |4 aut | |
245 | 1 | 0 | |a COVID-19 vaccination hesitancy among Americans with disabilities aged 18-65 |b An exploratory analysis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.12.2021 | ||
500 | |a Date Revised 03.04.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: It is important for people with disabilities to be vaccinated against COVID-19 because, as a group, they are at increased risk of severe outcomes. While there are multiple vaccines available to prevent COVID-19, a considerable proportion of Americans report some hesitancy to becoming vaccinated, including people with disabilities | ||
520 | |a OBJECTIVE: We conducted a study to explore what factors may contribute to COVID-19 vaccination hesitancy among Americans with disabilities | ||
520 | |a METHODS: We used Amazon's Mechanical Turk to survey 439 people with disabilities (ages 18+) about their concerns of the COVID-19 disease, vaccines, and hesitancy toward vaccination to learn more about factors that influence vaccination hesitancy. Concerns about vaccines were analyzed as a composite variable representing different dimensions such as: side effects, too new, developed too quickly, influenced by politics, and effectiveness | ||
520 | |a RESULTS: Results from a logistic regression indicate that concern about vaccines was the most significant predictor of hesitancy, even after considering demographic, economic, and geographic factors. Concerns about getting COVID-19, getting tested for COVID-19, trust in experts, education, and being a Democrat were negatively associated with hesitancy | ||
520 | |a CONCLUSIONS: These findings indicate that some groups of individuals may be more vaccination hesitant because they are more concerned about vaccine safety than COVID-19 infection. Public health messaging that focuses on the risks of vaccines relative to the risks of COVID-19 might be one strategy to reduce hesitancy and increase vaccination uptake. Messaging should also be tailored to specific disabilities (i.e. physical, mental, sensory), written in plain language, and disseminated in accessible formats | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Disability | |
650 | 4 | |a Pandemic | |
650 | 4 | |a Public health | |
650 | 4 | |a Vaccination hesitancy | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
700 | 1 | |a Ipsen, Catherine |e verfasserin |4 aut | |
700 | 1 | |a Lissau, Ari |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Disability and health journal |d 2008 |g 15(2022), 1 vom: 29. Jan., Seite 101223 |w (DE-627)NLM192538179 |x 1876-7583 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2022 |g number:1 |g day:29 |g month:01 |g pages:101223 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.dhjo.2021.101223 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2022 |e 1 |b 29 |c 01 |h 101223 |